Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/154942
Title: | The one year fate of iron oxide coated gold nanoparticles in mice |
Author: | Kolosnjaj-Tabi, Jelena Javed, Yasir Lartigue, Lénaic Volatron, Jeanne Elgrabli, Dan Marangon, Iris Pugliese, Giammarino Caron, Benoit Figuerola i Silvestre, Albert Luciani, Nathalie Pellegrino, Teresa Alloyeau, Damien Gazeau, Florence |
Keywords: | Nanopartícules Proteïnes Nanoparticles Proteins |
Issue Date: | 13-Jul-2015 |
Publisher: | American Chemical Society |
Abstract: | Safe implementation of nanotechnology and nanomedicine requires an in-depth understanding of the life cycle of nanoparticles in the body. Here, we investigate the long-term fate of gold/iron oxide heterostructures after intravenous injection in mice. We show these heterostructures degrade in vivo and that the magnetic and optical properties change during the degradation process. These particles eventually eliminate from the body. The comparison of two different coating shells for heterostructures, amphiphilic polymer or polyethylene glycol, reveals the long lasting impact of initial surface properties on the nanocrystal degradability and on the kinetics of elimination of magnetic iron and gold from liver and spleen. Modulation of nanoparticles reactivity to the biological environment by the choice of materials and surface functionalization may provide new directions in the design of multifunctional nanomedicines with predictable fate. |
Note: | Versió postprint del document publicat a: https://doi.org/10.1021/acsnano.5b00042 |
It is part of: | ACS Nano, 2015, vol. 9, num. 8, p. 7925-7939 |
URI: | https://hdl.handle.net/2445/154942 |
Related resource: | https://doi.org/10.1021/acsnano.5b00042 |
ISSN: | 1936-0851 |
Appears in Collections: | Articles publicats en revistes (Química Inorgànica i Orgànica) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
654948.pdf | 2.61 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.